Revilico
1 known investors
Revilico builds an operating system for pharmaceutical R&D that unifies computational drug discovery tools—including molecular dynamics, quantum chemistry, generative chemistry, and virtual cell simulations—with integrated wet-lab validation. The platform serves pharmaceutical researchers and biotech companies developing small molecule drugs, covering all phases from target identification through lead optimization and preclinical development.
AI & Machine LearningBiotechDeep Tech